NervGen Pharma Corp. (NGEN) — Financial Flexibility Index
NervGen Pharma Corp. (NGEN) has a Financial Flexibility Index of -0.08x as of June 2026. Free cash flow of $-5.81 Million (operating CF $-5.81 Million minus capex $0.00) represents 0% of total liabilities ($73.03 Million). Check NGEN tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NervGen Pharma Corp. Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for NervGen Pharma Corp. across 8 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of NervGen Pharma Corp..
Annual Financial Flexibility Index for NervGen Pharma Corp. (2018–2025)
Year-by-year free cash flow to debt coverage for NervGen Pharma Corp.. Explore debt repayment capacity of NervGen Pharma Corp. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.99x | $-19.50 Million | $-19.50 Million | $19.73 Million | ▲ +0.8% |
| 2024 | -1.00x | $-16.83 Million | $-16.83 Million | $16.90 Million | ▼ -34.5% |
| 2023 | -0.74x | $-11.29 Million | $-11.30 Million | $15.25 Million | ▲ +56.6% |
| 2022 | -1.71x | $-17.61 Million | $-17.63 Million | $10.32 Million | ▲ +77.8% |
| 2021 | -7.67x | $-8.33 Million | $-8.33 Million | $1.09 Million | ▲ +8.2% |
| 2020 | -8.35x | $-6.32 Million | $-6.32 Million | $756.78K | ▲ +4.7% |
| 2019 | -8.76x | $-8.31 Million | $-8.31 Million | $949.14K | ▼ -391.1% |
| 2018 | -1.78x | $-1.04 Million | $-1.04 Million | $581.26K | — |